Sponsored Links
| Thalidomide Does Not Improve Survival In Small Cell Lung Cancer: Journal Of The National Cancer Institute News Brief |
 |
 |
 |
| Medical News - Hematology | |||
|
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute. Siow Ming Lee, M.D., of the Department of Oncology, University Hospital in London, and colleagues randomly assigned 724 SCLC patients to take either a placebo or thalidomide. Read more: Blood / Hematology News From Medical News Today
|